Oryzon Genomics has appointed Rolando Gutierrez-Esteinou, as chief medical officer [...]

Endometriosis is typically treated as a single condition, yet patients [...]

Newron has expanded the intellectual property protection for its lead [...]

Boehringer Ingelheim and Click Therapeutics have reported Phase 3 results [...]

Celon Pharma S.A. has received FDA clearance to advance its [...]

Alto Neuroscience has received FDA Fast Track designation for its [...]

Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium [...]

Newron Pharmaceuticals has highlighted new preclinical findings published in Neuropsychopharmacology [...]

An investigational prescription digital therapeutic (PDT) designed to treat negative [...]